Showing results (41-50 of 91) with videos related to
Sort By:
Pageof 10
Neurology|October 19, 2018
Use of newer disease-modifying therapies in pediatric multiple sclerosis in the USKristen M Krysko, Jennifer Graves, Mary Rensel, et al.Journal of Neurology|January 15, 2025
Ocrelizumab dose selection for treatment of pediatric relapsing-remitting multiple sclerosis: results of the OPERETTA I studySoe Mar, Massimiliano Valeriani, Barbara Steinborn, et al.Multiple Sclerosis and Related Disorders|March 15, 2025
Limited early IVIG for the treatment of pediatric myelin oligodendrocyte glycoprotein antibody-associated diseaseRebecca MacRae, Jonathan Race, Allison Schuette, et al.Multiple Sclerosis and Related Disorders|June 5, 2024
Clinical and magnetic resonance imaging outcomes in pediatric-onset MS patients on fingolimod and ocrelizumabZahra Nasr, T Charles Casper, Michael Waltz, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|July 30, 2024
Association of nutritional intake with clinical and imaging activity in pediatric multiple sclerosisSonam D Mohan, Skyler Peterson, J Nicholas Brenton, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|March 24, 2023
Characteristics of pediatric patients with multiple sclerosis and related disorders infected with SARS-CoV-2Teri Schreiner, Molly Wilson-Murphy, Jan Mendelt-Tillema, et al.Annals of Clinical and Translational Neurology|January 19, 2017
Distinct effects of obesity and puberty on risk and age at onset of pediatric MSTanuja Chitnis, Jennifer Graves, Bianca Weinstock-Guttman, et al.Journal of Child Neurology|September 16, 2025
Evaluating Efficacy Outcomes in Pediatric Multiple Sclerosis Patients While Using Avonex or Plegridy via USNPMSC RegistryMelissa A Wright, Bradley J Barney, Skyler Peterson, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|February 9, 2024
Gene-environment interactions: Epstein-Barr virus infection and risk of pediatric-onset multiple sclerosisAmin Ziaei, Olivia Solomon, T Charles Casper, et al.Eneuro|October 20, 2015
CSF and Blood Levels of GFAP in Alexander DiseasePaige L Jany, Guillermo E Agosta, William S Benko, et al.Pageof 10